BTG Pactual Global Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

BTG Pactual Global Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,939	Closed	-$513K	–	55
2018 Q3	$513K	Sell	9,939 -19,959	-67%	-$938K	0.21%	38
2018 Q2	$1.25M	Buy	29,898 +1,236	+4%	+$54.8K	0.36%	39
2018 Q1	$1.26M	Buy	28,662 +3,434	+14%	+$174K	0.34%	38
2017 Q4	$1.27M	Buy	25,228 +853	+3%	+$46.8K	0.46%	31
2017 Q3	$1.24M	Sell	24,375 -1,013	-4%	-$53.1K	0.39%	39
2017 Q2	$1.29M	Buy	25,388 +5,743	+29%	+$267K	0.37%	44
2017 Q1	$790K	Buy	+19,645	New	+$882K	0.29%	50
2016 Q2	–	Sell	-5,165	Closed	-$209K	–	51
2016 Q1	$209K	Buy	+5,165	New	+$210K	0.51%	34

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

BTG Pactual Global Asset Management's IONS Position: Q4 2018 in Review

BTG Pactual Global Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2018, closing a stake of 9,939 shares — an estimated $513K sold.

BTG Pactual Global Asset Management first reported a position in IONS in Q1 2016 and held it in 8 quarters. The position peaked at $1.29M in Q2 2017. 330 funds tracked by Wall St. Rank hold IONS as of Q4 2018.

BTG Pactual Global Asset Management reported no remaining Ionis Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
BTG Pactual Global Asset Management sold 9,939 Ionis Pharmaceuticals shares in Q4 2018, an estimated $513K.
BTG Pactual Global Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2016 and held it in 8 quarters.
BTG Pactual Global Asset Management's Ionis Pharmaceuticals position peaked at $1.29M in Q2 2017.
330 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2018.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.